Yousif Capital Management LLC Reduces Position in Henry Schein, Inc. (NASDAQ:HSIC)

Yousif Capital Management LLC lessened its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 3.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,144 shares of the company’s stock after selling 690 shares during the period. Yousif Capital Management LLC’s holdings in Henry Schein were worth $1,380,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. Invesco Ltd. boosted its holdings in Henry Schein by 0.4% during the 4th quarter. Invesco Ltd. now owns 4,963,409 shares of the company’s stock valued at $343,468,000 after acquiring an additional 17,552 shares during the period. FMR LLC boosted its holdings in shares of Henry Schein by 6.6% in the fourth quarter. FMR LLC now owns 3,498,033 shares of the company’s stock valued at $242,064,000 after purchasing an additional 217,143 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Henry Schein by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company’s stock valued at $218,762,000 after purchasing an additional 14,876 shares during the period. Palestra Capital Management LLC purchased a new stake in shares of Henry Schein in the fourth quarter valued at approximately $182,988,000. Finally, Fiduciary Management Inc. WI lifted its holdings in shares of Henry Schein by 7.2% in the 4th quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company’s stock worth $172,193,000 after buying an additional 167,990 shares during the period. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Price Performance

Shares of Henry Schein stock opened at $70.16 on Wednesday. The company has a quick ratio of 0.75, a current ratio of 1.38 and a debt-to-equity ratio of 0.50. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The business has a 50-day moving average price of $68.54 and a 200 day moving average price of $71.34. The firm has a market cap of $8.54 billion, a PE ratio of 21.93, a P/E/G ratio of 2.28 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.04. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. Henry Schein’s revenue for the quarter was down .1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.10 EPS. Sell-side analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on HSIC shares. UBS Group lowered their price target on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday, February 26th. Piper Sandler decreased their target price on shares of Henry Schein from $83.00 to $77.00 and set an “overweight” rating for the company in a research report on Wednesday, April 30th. Wall Street Zen lowered Henry Schein from a “buy” rating to a “hold” rating in a report on Thursday, April 17th. Wells Fargo & Company decreased their price target on Henry Schein from $80.00 to $75.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 6th. Finally, Barrington Research decreased their price target on Henry Schein from $90.00 to $86.00 and set an “outperform” rating for the company in a research note on Tuesday, May 6th. Six investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $79.30.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.